Betaserc Odis

Medicinal product

(Invented) name

Betaserc Odis

Active substance (s)

Betahistino dihidrochloridas

Strength

24 mg

Pharmaceutical form

burnoje disperguojamos tabletės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

N07CA01, Betahistine

Marketing authorisation holder

UAB Lex ano, Lietuva

Date of authorisation

2023-11-22

Date of renewal

Documents

2030_Betaserc Odis_2024-02-07_K.docx

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

Procedure number

Marketing authorisation procedure

Lygiagretus importas

Qualitative and quantitative composition

Tabletėje yra	1 vnt.
Betahistino dihidrochloridas	24 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
112155	98270	1098270	lizdinė plokštelė	N20		Receptinis	LT/L/23/2030/001	Netiekiama	-	-	No	-	-
112156	98271	1098271	lizdinė plokštelė	N60		Receptinis	LT/L/23/2030/002	Tiekiama	-	-	No	-	-	Download

Stadijos

Data	Stadija
2023-11-22	Registruotas